1903 related articles for article (PubMed ID: 12820234)
1. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
2. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.
Ishih A; Suzuki T; Watanabe M; Miyase T; Terada M
Phytother Res; 2003 Dec; 17(10):1234-6. PubMed ID: 14669265
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antimalarial activity of the alkaloidal fraction of Hydrangea macrophylla var. Otaksa leaves with the hot-water extract in ICR mice infected with Plasmodium yoelii 17 XL.
Ishih A; Miyase T; Terada M
Phytother Res; 2003 Jun; 17(6):633-9. PubMed ID: 12820231
[TBL] [Abstract][Full Text] [Related]
4. A potent antimalarial activity of Hydrangea macrophylla var. Otaksa leaf extract against Plasmodium yoelii 17XL in mice.
Ishih A; Ikeya C; Yanoh M; Takezoe H; Miyase T; Terada M
Parasitol Int; 2001 Mar; 50(1):33-9. PubMed ID: 11267930
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and antibody production during the course of resolution in Plasmodium yoelii 17XL-infected BALB/c mice treated with febrifugine and isofebrifugine mixture from leaves of Hydrangea macrophylla var. Otaksa.
Ishih A; Nagata T; Kobayashi F; Miyase T; Terada M
Parasitol Res; 2004 Oct; 94(3):176-82. PubMed ID: 15338283
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
Ishih A; Suzuki T; Muregi FW; Matsui K; Terada M
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of IFN-gamma in early mortality of Plasmodium berghei NK65-infected BALB/c mice after febrifugine treatment.
Ishih A; Nagata T; Kobayashi F; Muregi FW; Ohori K; Miyase T
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):949-58. PubMed ID: 19062681
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
Nurul Aiezzah Z; Noor E; Hasidah MS
Trop Biomed; 2010 Dec; 27(3):624-31. PubMed ID: 21399604
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence.
Nakazawa S
Exp Parasitol; 2005 Sep; 111(1):59-63. PubMed ID: 15961077
[TBL] [Abstract][Full Text] [Related]
11. In vivo antimalarial activity of leaves of Plectranthus amboinicus (lour) spreng on Plasmodium berghei yoelii.
Periyanayagam K; Nirmala Devi K; Suseela L; Uma A; Ismail M
J Commun Dis; 2008 Jun; 40(2):121-5. PubMed ID: 19301696
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
13. [Malaria plasmodia in the mouse. Parasitization of mature and immature erythrocytes by Plasmodium berghei, Plasmodium yoelii and Plasmodium chabaudi (author's transl)].
Büngener W
Tropenmed Parasitol; 1979 Jun; 30(2):198-205. PubMed ID: 384629
[TBL] [Abstract][Full Text] [Related]
14. Potentiation by febrifugine of host defense in mice against Plasmodium berghei NK65.
Murata K; Takano F; Fushiya S; Oshima Y
Biochem Pharmacol; 1999 Nov; 58(10):1593-601. PubMed ID: 10535750
[TBL] [Abstract][Full Text] [Related]
15. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
17. Anti-malarial activity of leaf-extract of hydrangea macrophylla, a common Japanese plant.
Kamei K; Matsuoka H; Furuhata SI; Fujisaki RI; Kawakami T; Mogi S; Yoshihara H; Aoki N; Ishii A; Shibuya T
Acta Med Okayama; 2000 Oct; 54(5):227-32. PubMed ID: 11061572
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium chabaudi chabaudi: effect of low parasitemias on immunity in CB6F1 mice.
Favila-Castillo L; Monroy-Ostria A; Garcia-Tapia D
Exp Parasitol; 1999 May; 92(1):73-80. PubMed ID: 10329368
[TBL] [Abstract][Full Text] [Related]
19. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice.
Muregi FW; Ishih A; Suzuki T; Kino H; Amano T; Mkoji GM; Miyase T; Terada M
Phytother Res; 2007 Apr; 21(4):337-43. PubMed ID: 17221829
[TBL] [Abstract][Full Text] [Related]
20. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
Fink E
Bull World Health Organ; 1974; 50(3-4):213-22. PubMed ID: 4155355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
